Toxic Epidermal Necrolysis/Stevens-Johnson Syndrome at a University Hospital in Saudi: Causative Factors and Outcomes

被引:0
|
作者
Kokandi, Amal A. [1 ,2 ]
机构
[1] King Abdulaziz Univ, Fac Med, Dept Dermatol, Jeddah, Saudi Arabia
[2] King Abdulaziz Univ Hosp, Jeddah, Saudi Arabia
关键词
Stevens-Johnson syndrome; Toxic epidermal necrolysis; Drug reaction; PATIENT; DRUGS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS) are rare, life-threatening conditions caused mainly by drugs. Their management relies on the withdrawal of the culprit medication and supportive measures. Different pharmacotherapies have varied effects. However, data related to TEN and SJS in Saudi is limited. Objective: This study aimed to identify the causative agents, associated factors, and outcomes of TEN/SJS cases admitted to a teaching hospital (King Abdulaziz University) in Jeddah during the last 10 years. Methods: retrospective descriptive study. The data of patients admitted to the King Abdulaziz University hospital with TEN/SJS diagnosis over the last 10 years were collected Result: We identified 12 patients with TEN/SJS. Of these, nine survived the condition and were discharged. The culprit medication was identified in eight of them, including antibiotics in six cases and Tegretol and allopurinol in one case each. Most of the patients received systemic steroids and intravenous immunoglobulins. Conclusion: TEN/SJS is mainly caused by medications of which antibiotics are the most implicated. Consistent with other studies, the mortality rate associated with TEN/SJS in Saudi is 25%. Limitations: restricted to a single center and small sample size.
引用
收藏
页码:1129 / 1132
页数:4
相关论文
共 50 条
  • [41] Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis
    Valeyrie-Allanore, L.
    Wolkenstein, P.
    Brochard, L.
    Ortonne, N.
    Maitre, B.
    Revuz, J.
    Bagot, M.
    Roujeau, J. C.
    BRITISH JOURNAL OF DERMATOLOGY, 2010, 163 (04) : 847 - 853
  • [42] Clinical characteristics and treatment outcome of Stevens-Johnson syndrome and toxic epidermal necrolysis
    Chantaphakul, Hiroshi
    Sanon, Thanomsak
    Klaewsongkram, Jettanong
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 10 (02) : 519 - 524
  • [43] Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the clinical experience of a University Hospital (1989-2008)
    Ferrandiz-Pulido, Carla
    Garcia-Fernandez, Daniel
    Gomez-Morell, Pablo
    Palao, Ricard
    Garcia-Patos, Vicente
    MEDICINA CLINICA, 2011, 136 (13): : 583 - 587
  • [44] French referral center management of Stevens-Johnson syndrome/toxic epidermal necrolysis
    Valeyrie-Allanore, Laurence
    Ingen-Housz-Oro, Saskia
    Chosidow, Olivier
    Wolkenstein, Pierre
    DERMATOLOGICA SINICA, 2013, 31 (04) : 191 - 195
  • [45] Stevens-Johnson syndrome and toxic epidermal necrolysis: A fresh look at an old foe
    Kaimal, Sowmya
    Lobo, Carol
    Narayan, Girish
    Augustine, Mary
    INDIAN JOURNAL OF DERMATOLOGY, 2023, 68 (01) : 34 - 40
  • [46] Stevens-Johnson syndrome, toxic epidermal necrolysis and phenytoin factors linked to a higher risk
    Gómez-Criado, MS
    Ayani, I
    León-Colombo, T
    Ramos, ML
    Reneses, MJ
    REVISTA DE NEUROLOGIA, 2004, 38 (11) : 1056 - 1060
  • [47] Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: What Do We Know?
    Tartarone, Alfredo
    Lerose, Rosa
    THERAPEUTIC DRUG MONITORING, 2010, 32 (06) : 669 - 672
  • [48] Management of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: a Review and Update
    Jennifer L. Coias
    Laila F. Abbas
    Adela R. Cardones
    Current Dermatology Reports, 2019, 8 : 219 - 233
  • [49] Aceclofenac induced Stevens-Johnson/toxic epidermal necrolysis overlap syndrome
    Ameen, Kaderthambi Hajamohideen Nooru
    Pinninti, Rakesh
    Jami, Swathi
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2013, 4 (01) : 69 - 71
  • [50] Current Pharmacogenetic Perspective on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    Cheng, Lin
    FRONTIERS IN PHARMACOLOGY, 2021, 12